News

Incubating inventions through technology transfer

Irene Abrams, executive director of the Office of Technology Licensing, talks about building the entrepreneurial ecosystem that will support faculty-industry relationships and lead to technology commercialization, licensing, industry-sponsored research and faculty spin-off companies, networking opportunities for students, and, ultimately, royalties to Brandeis.

Brandeis and Smart Balance team up to advance heart-healthy research

WALTHAM, Mass. (Nov. 5, 2008) —Brandeis University has announced a multi-year $1 million sponsored research agreement with Smart Balance, Inc. through its wholly owned subsidiary, the maker of Smart Balance® buttery spread and other low-fat and fat-free foods that help lower cholesterol through a patented blend of natural vegetable oils. In addition, Brandeis and Smart Balance have entered into a collaboration and license to develop a second-generation heart-healthy fat for Smart Balance. > Read more...

Larry WanghBrandeis disease detection technology licensed to global leader

WALTHAM, Mass. (Oct. 17, 2007) — Smiths Detection, part of the global technology business Smiths Group, has announced it will launch a portable detection system that will enable veterinarians to carry out on-site diagnosis of animal diseases such as foot-and-mouth and avian flu. This new technology means vets will be able to diagnose diseases in livestock and birds in the field in less than 90 minutes rather than having to send samples for laboratory analysis. > Read more...

Corazonas Foods and Brandeis partner to create innovative cholesterol-reducing snacks

WALTHAM, Mass. (Oct. 8, 2007) — Corazonas Foods, Inc., creators of great-tasting, heart-healthy snack foods, has announced an exclusive licensing agreement with Brandeis University to utilize their technology in creating several new categories of heart-healthy snacks.  Brandeis’ innovative technology allows high levels of plant sterols to be incorporated into snack foods while retaining the product’s outstanding flavor.  The partnership’s first venture, Corazonas Heart-Healthy Tortilla Chips, are currently the first and only snack chips clinically proven to reduce low-density lipoprotein (LDL) cholesterol, a.k.a. “bad cholesterol,” by up to 15 percent.  The chips have been a huge hit since debuting in early 2006, further demonstrating the overwhelming consumer demand for healthful snack alternatives without sacrificing great taste. > Read more...

To Market, to Market

At Brandeis, what goes on in the laboratory does not necessarily stay in the laboratory. Our works on technology commercialization have been featured in the cover story of the Brandeis University Magazine 2007 Summer issue.

Download a PDF of the article.

Brandeis and Brigham and Women’s Hospital license technology for Gaucher Disease to Amicus Therapeutics

WALTHAM, Mass. (Feb. 22, 2007) -- Brandeis University and Brigham and Women’s Hospital today agreed to grant a license option to Amicus Therapeutics for a jointly-developed novel pharmaceutical technology that could be instrumental in finding new treatments for Gaucher Disease. Biochemists Raquel Lieberman, Gregory Petsko and Dagmar Ringe, each affiliated with both Brandeis and Brigham and Women’s, invented a patentable technology related to the structure of acid beta-glucosidase, also known as GCase, and methods for identifying therapeutic agents. > Read more...

Giant biotech acquires Brandeis spin-out

WALTHAM, Mass. (Jan. 31, 2007) -- Syntonix Pharmaceuticals, a spin-out company formed by Brandeis University, Brigham and Women’s Hospital, and Children’s Hospital, Boston announced today that it was acquired by biotech giant Biogen Idec (NASDAQ: BIIB - News). Syntonix, a privately held biopharmaceutical company, was founded in 1997 based on breakthrough discoveries from the laboratories of Neil Simister, Ph.D. (Brandeis), Wayne Lencer, M.D. (Children’s), and Richard S. Blumberg, M.D. (Brigham). Their research harnesses the human body’s natural immunological pathways for novel methods of drug delivery. > Read more…

K.C. HayesResearchers find way to produce cholesterol-lowering snack chips

WALTHAM, Mass. (Jan. 31, 2005) -- Brandeis University biology professor K.C. Hayes and Senior Research Associate Andy Pronczuk at the school’s Foster Biomedical Research Laboratory, in collaboration with Brandeis Senior Scientist Daniel Perlman of the Physics Department, have discovered a way to produce chips and other snack foods that can actually lower your cholesterol while you eat them without having any impact on taste.  > Read more…